Institution
Australian Catholic University
Education•Brisbane, Queensland, Australia•
About: Australian Catholic University is a education organization based out in Brisbane, Queensland, Australia. It is known for research contribution in the topics: Population & Poison control. The organization has 2721 authors who have published 10013 publications receiving 215248 citations. The organization is also known as: ACU & ACU National.
Papers published on a yearly basis
Papers
More filters
TL;DR: The application of molecular techniques to exercise biology has provided greater understanding of the multiplicity and complexity of cellular networks involved in exercise responses, and recent discoveries offer perspectives on the mechanisms by which muscle "communicates" with other organs and mediates the beneficial effects of exercise on health and performance.
720 citations
University of Melbourne1, University of Washington2, Pontifícia Universidade Católica do Paraná3, Federal University of Paraná4, Washington University in St. Louis5, Australian Catholic University6, Queensland University of Technology7, University of Western Australia8, University of California, San Diego9, Swinburne University of Technology10, Baker IDI Heart and Diabetes Institute11
TL;DR: In this paper, the authors identify eight integrated regional and local interventions that, when combined, encourage walking, cycling, and public transport use, while reducing private motor vehicle use, and recommend establishing a set of indicators to benchmark and monitor progress towards achievement of more compact cities that promote health and reduce health inequities.
704 citations
TL;DR: The identification of meteorin-like (Metrnl), a circulating factor that is induced in muscle after exercise and in adipose tissue upon cold exposure, which links host-adaptive responses to the regulation of energy homeostasis and tissue inflammation and has therapeutic potential for metabolic and inflammatory diseases.
680 citations
TL;DR: The empirical results show that listed firms across these countries, financial and non-financial firms alike, experience significant increase in conditional correlations between their stock returns, however, the magnitude of increase in these correlations is considerably higher for financial firms during the COVID-19 outbreak.
533 citations
Case Western Reserve University1, Johns Hopkins University2, Mayo Clinic3, Harvard University4, University of Tennessee Health Science Center5, Australian Catholic University6, University of Kentucky7, University of Washington8, University of Pennsylvania9, Memorial Sloan Kettering Cancer Center10, New York Medical College11, Université de Montréal12, Martin Luther University of Halle-Wittenberg13, Centra14
TL;DR: This guideline provides timely, evidence-based reversal strategies to assist practitioners in the care of patients with antithrombotic-associated intracranial hemorrhage.
Abstract: The use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is expected to continue to rise. Although antithrombotic-associated intracranial hemorrhage can be devastating, rapid reversal of coagulopathy may help limit hematoma expansion and improve outcomes. The Neurocritical Care Society, in conjunction with the Society of Critical Care Medicine, organized an international, multi-institutional committee with expertise in neurocritical care, neurology, neurosurgery, stroke, hematology, hemato-pathology, emergency medicine, pharmacy, nursing, and guideline development to evaluate the literature and develop an evidence-based practice guideline. Formalized literature searches were conducted, and studies meeting the criteria established by the committee were evaluated. Utilizing the GRADE methodology, the committee developed recommendations for reversal of vitamin K antagonists, direct factor Xa antagonists, direct thrombin inhibitors, unfractionated heparin, low-molecular weight heparin, heparinoids, pentasaccharides, thrombolytics, and antiplatelet agents in the setting of intracranial hemorrhage. This guideline provides timely, evidence-based reversal strategies to assist practitioners in the care of patients with antithrombotic-associated intracranial hemorrhage.
524 citations
Authors
Showing all 2824 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| John J.V. McMurray | 178 | 1389 | 184502 |
| James F. Sallis | 169 | 825 | 144836 |
| Richard M. Ryan | 164 | 405 | 244550 |
| Herbert W. Marsh | 152 | 646 | 89512 |
| Jacquelynne S. Eccles | 136 | 378 | 84036 |
| John A. Kanis | 133 | 625 | 96992 |
| Edward L. Deci | 130 | 284 | 206930 |
| Thomas J. Ryan | 116 | 675 | 67462 |
| Bruce E. Kemp | 110 | 423 | 45441 |
| Mark J. Nieuwenhuijsen | 107 | 647 | 49080 |
| Peter Rosenbaum | 103 | 446 | 45732 |
| Barbara Riegel | 101 | 507 | 77674 |
| Ego Seeman | 101 | 529 | 46392 |
| Paul J. Frick | 100 | 306 | 33579 |
| Robert J. Vallerand | 98 | 301 | 41840 |